Effect of graft steatosis on liver function and organ survival after liver transplantation

American Journal of Surgery

Volumn 195, Issue 2, 2008, Pages 214-220

  Angele, Martin K ^a   Rentsch, Markus ^a   Hartl, Wolfgang H ^a   Wittmann, Benedikt ^a   Graeb, Christian ^a   Jauch, Karl Walter ^a   Loehe, Florian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Liver function; Liver steatosis; Liver transplantation; Organ blood flow; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONFIDENCE INTERVAL; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; STATISTICAL SIGNIFICANCE;

ADULT; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRCULATION; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 38049030082     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.02.023     Document Type: Article

References (31)

1. Marsman W.A., Wiesner R.H., Rodriguez L., et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62 (1996) 1246-1251
2. Koneru B., and Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 73 (2002) 325-333
3. Rinella M.E., Alonso E., Rao S., et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transplant 7 (2001) 409-414
4. Adam R., Reynes M., Johann M., et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 23 (1991) 1538-1544
5. Todo S., Demetris A.J., Makowka L., et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47 (1989) 903-905
6. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 (1993) 807-813
7. Yoo H.Y., Molmenti E., and Thuluvath P.J. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transplant 9 (2003) 72-78
8. Chui A.K., Shi L.W., Rao A.R., et al. Primary graft dysfunction after liver transplantation. Transplant Proc 37 (2000) 2219-2222
9. Fishbein T.M., Fiel M.I., Emre S., et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64 (1997) 248-251
10. Soejima Y., Shimada M., Suehiro T., et al. Use of steatotic graft in living-donor liver transplantation. Transplantation 76 (2003) 344-348
11. Imber C.J., St Peter S.D., Handa A., et al. Hepatic steatosis and its relationship to transplantation. Liver Transplant 8 (2002) 415-423
12. Selzner M., and Clavien P.A. Fatty liver in liver transplantation and surgery. Semin Liver Dis 21 (2001) 105-113
13. Imber C.J., St Peter S.D., Lopez I., et al. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transplant 8 (2002) 545-549
14. Adam R., Cailliez V., Majno P., et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 356 (2000) 621-627
15. Salizzoni M., Franchello A., Zamboni F., et al. Marginal grafts: finding the correct treatment for fatty livers. Transplant Int 16 (2003) 486-493
16. Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci 9 (2005) 295-297
17. Yoong K.F., Gunson B.K., Neil D.A., et al. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 31 (1999) 550-551
18. Zamboni F., Franchello A., David E., et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15 (2001) 53-57
19. Fernandez-Merino F.J., Nuno-Garza J., Lopez-Hervas P., et al. Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. Transplant Proc 35 (2003) 1793-1794
20. Cho J.Y., Suh K.S., Kwon C.H., et al. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transplant 11 (2005) 210-217
21. Busquets J., Figueras J., Serrano T., et al. Postreperfusion biopsy changes predict biliary complications after liver transplantation. Transplant Proc 34 (2002) 256-258
22. Afonso R.C., Saad W.A., Parra O.M., et al. Impact of steatotic grafts on initial function and prognosis after liver transplantation. Transplant Proc 36 (2004) 909-911
23. Spannbauer M.M., Oleszczuk A., Tannapfel A., et al. Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet. Transplant Proc 37 (2005) 210-211
24. Yamagami K., Hutter J., Yamamoto Y., et al. Synergistic effects of brain death and liver steatosis on the hepatic microcirculation. Transplantation 80 (2005) 500-505
25. Ijaz S., Yang W., Winslet M.C., et al. The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis. Microvasc Res 70 (2005) 129-136
26. Urena M.A., Moreno G.E., Romero C.J., et al. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology 46 (1999) 1164-1173
27. Ijaz S., Yang W., Winslet M.C., et al. Impairment of hepatic microcirculation in fatty liver. Microcirculation 10 (2003) 447-456
28. Seifalian A.M., Piasecki C., Agarwal A., et al. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 68 (1999) 780-784
29. Serafin A., Rosello-Catafau J., Prats N., et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 161 (2002) 587-601
30. Schauer R.J., Bilzer M., Kalmuk S., et al. Microcirculatory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction. Transplantation 72 (2001) 1692-1699
31. Lohe F., Angele M.K., Gerbes A.L., et al. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol 31 (2005) 994-999